OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NEOE59

Neogen Chemicals Ltd

Specialty ChemicalsVerified

Neogen Chemicals Ltd has a debt-to-equity ratio of 0.76, indicating a moderate level of leverage, and a current ratio of 1.36, suggesting adequate short-term liquidity to cover its obligations. However, the company's free cash flow is negative at -2.6 billion INR, and capital expenditures are high at -3.18 billion INR, which may signal significant reinvestment in operations or asset base. The company's liquidity position is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt. In terms of profitability, Neogen Chemicals Ltd has a return on equity (ROE) of 4.41% and a return on assets (ROA) of 1.99%, which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 944.5 million INR and net income of 348.3 million INR reflect a relatively modest profit margin, which may be influenced by competitive pressures or cost management challenges. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which could expose it to regional economic or regulatory risks. The lack of segment or geographic breakdown in the financial data suggests a need for further transparency to assess the company's exposure to different markets or product lines. Looking ahead, the company's growth trajectory is uncertain, as the outlook for the current and next fiscal years is not provided in the available data. However, the company's operating cash flow of 1.96 billion INR indicates some capacity to fund operations and potentially support growth initiatives. The absence of a clear growth narrative or segment-specific outlooks limits the ability to assess the company's strategic direction. The risk assessment for Neogen Chemicals Ltd highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity concern, and the dilution potential is assessed as low, with no significant dilution sources identified in the available data. The company's capital structure and financial flexibility will be important to monitor in the coming periods. Recent events and filings for Neogen Chemicals Ltd are not detailed in the available data, which limits the ability to assess the company's recent performance or strategic developments. The absence of recent transcripts or filings may indicate a lack of public disclosure or a focus on internal operations. Investors and analysts may need to rely on future disclosures to gain a clearer understanding of the company's direction.

30-day price · NEOE+386.00 (+27.8%)
Low$1313.30High$1883.00Close$1774.40As of26 May, 00:00 UTC
Profile
CompanyNeogen Chemicals Ltd
TickerNEOE.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Neogen Chemicals Ltd is a specialty chemicals company that produces and sells chemical products for industrial and consumer applications, primarily in the basic materials sector.

Classification. Neogen Chemicals Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Neogen Chemicals Ltd has a debt-to-equity ratio of 0.76, indicating a moderate level of leverage, and a current ratio of 1.36, suggesting adequate short-term liquidity to cover its obligations. However, the company's free cash flow is negative at -2.6 billion INR, and capital expenditures are high at -3.18 billion INR, which may signal significant reinvestment in operations or asset base. The company's liquidity position is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt. In terms of profitability, Neogen Chemicals Ltd has a return on equity (ROE) of 4.41% and a return on assets (ROA) of 1.99%, which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 944.5 million INR and net income of 348.3 million INR reflect a relatively modest profit margin, which may be influenced by competitive pressures or cost management challenges. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which could expose it to regional economic or regulatory risks. The lack of segment or geographic breakdown in the financial data suggests a need for further transparency to assess the company's exposure to different markets or product lines. Looking ahead, the company's growth trajectory is uncertain, as the outlook for the current and next fiscal years is not provided in the available data. However, the company's operating cash flow of 1.96 billion INR indicates some capacity to fund operations and potentially support growth initiatives. The absence of a clear growth narrative or segment-specific outlooks limits the ability to assess the company's strategic direction. The risk assessment for Neogen Chemicals Ltd highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity concern, and the dilution potential is assessed as low, with no significant dilution sources identified in the available data. The company's capital structure and financial flexibility will be important to monitor in the coming periods. Recent events and filings for Neogen Chemicals Ltd are not detailed in the available data, which limits the ability to assess the company's recent performance or strategic developments. The absence of recent transcripts or filings may indicate a lack of public disclosure or a focus on internal operations. Investors and analysts may need to rely on future disclosures to gain a clearer understanding of the company's direction.
Key takeaways
  • Neogen Chemicals Ltd has a moderate level of leverage with a debt-to-equity ratio of 0.76 and a current ratio of 1.36.
  • The company's profitability metrics, including ROE of 4.41% and ROA of 1.99%, are below typical thresholds for strong performance in the specialty chemicals industry.
  • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which could expose it to regional economic or regulatory risks.
  • The company's free cash flow is negative at -2.6 billion INR, and capital expenditures are high at -3.18 billion INR, which may signal significant reinvestment in operations or asset base.
  • The risk assessment for Neogen Chemicals Ltd highlights a medium liquidity risk and a low dilution risk, with a key flag indicating that net cash is negative after subtracting total debt.
  • Recent events and filings for Neogen Chemicals Ltd are not detailed in the available data, which limits the ability to assess the company's recent performance or strategic developments.
  • # RATIONALES
  • {
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$7.78B
Gross profit$2.78B
Operating income$944.5M
Net income$348.3M
R&D
SG&A
D&A
SBC
Operating cash flow$1.96B
CapEx-$3.18B
Free cash flow-$2.60B
Total assets$17.47B
Total liabilities$9.58B
Total equity$7.89B
Cash & equivalents
Long-term debt$5.97B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.89B
Net cash-$5.97B
Current ratio1.4
Debt/Equity0.8
ROA2.0%
ROE4.4%
Cash conversion5.6%
CapEx/Revenue-40.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricNEOEActivity
Op margin12.1%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin4.5%4.1% medp25 0.1% · p75 8.8%above median
Gross margin35.8%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-40.9%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity76.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target1,784.29 INR
Median price target1,660.00 INR
High price target2,761.00 INR
Low price target1,335.00 INR
Mean recommendation1.29 (1=strong buy, 5=strong sell)
Strong-buy count6.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate8.74 INR
Last actual EPS18.54 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 17:40 UTC#bea6e038
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 17:34 UTCJob: 5a15a2c0